These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35370072)

  • 21. Outcomes of Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma in the Netherlands: A Nationwide Retrospective Analysis.
    de Rooij T; Tol JA; van Eijck CH; Boerma D; Bonsing BA; Bosscha K; van Dam RM; Dijkgraaf MG; Gerhards MF; van Goor H; van der Harst E; de Hingh IH; Kazemier G; Klaase JM; Molenaar IQ; Patijn GA; van Santvoort HC; Scheepers JJ; van der Schelling GP; Sieders E; Busch OR; Besselink MG;
    Ann Surg Oncol; 2016 Feb; 23(2):585-91. PubMed ID: 26508153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility of local therapy for recurrent pancreatic cancer.
    Sato H; Yoshida R; Yasui K; Umeda Y; Yoshida K; Fuji T; Kumano K; Takagi K; Yagi T; Fujiwara T
    Pancreatology; 2022 Sep; 22(6):774-781. PubMed ID: 35641368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of pancreatic adenocarcinoma that was not resected because of isolated para-aortic lymph node involvement.
    Marchese U; Ewald J; Gilabert M; Delpero JR; Turrini O
    J Visc Surg; 2019 Apr; 156(2):97-101. PubMed ID: 30026012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma.
    Jamiyan T; Shiraki T; Kurata Y; Ichinose M; Kubota K; Imai Y
    World J Surg Oncol; 2020 Jun; 18(1):137. PubMed ID: 32571348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?
    Buc E; Orry D; Antomarchi O; Gagnière J; Da Ines D; Pezet D
    World J Surg Oncol; 2014 Nov; 12():347. PubMed ID: 25407113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oligometastatic pulmonary metastasis in pancreatic cancer patients: Safety and outcome of resection.
    Ilmer M; Schiergens TS; Renz BW; Schneider C; Sargut M; Waligora R; Weniger M; Hartwig W; Ceyhan GO; Friess H; Werner J; D'Haese JG
    Surg Oncol; 2019 Dec; 31():16-21. PubMed ID: 31473583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of factors influencing recurrence and metastasis following curative resection of pancreatic ductal adenocarcinoma].
    Xie YB; Zhao P; Wang CF; Shan Y; Zhao DB; Liu Q; Bai XF
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):686-9. PubMed ID: 19173911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatic resection for M1 pancreatic ductal adenocarcinoma.
    Shrikhande SV; Kleeff J; Reiser C; Weitz J; Hinz U; Esposito I; Schmidt J; Friess H; Büchler MW
    Ann Surg Oncol; 2007 Jan; 14(1):118-27. PubMed ID: 17066229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
    Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR
    Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection.
    Sugawara T; Ban D; Nishino J; Watanabe S; Maekawa A; Ishikawa Y; Akahoshi K; Ogawa K; Ono H; Kudo A; Tanaka S; Tanabe M
    PLoS One; 2021; 16(4):e0249885. PubMed ID: 33844700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors predicting recurrence after left‑sided pancreatectomy for pancreatic ductal adenocarcinoma.
    Xia T; Xu P; Mou Y; Zhang X; Song S; Zhou Y; Lu C; Zhu Q; Xu Y; Jin W; Wang Y
    World J Surg Oncol; 2023 Jun; 21(1):191. PubMed ID: 37349737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic impact of para-aortic lymph node metastasis in pancreatic ductal adenocarcinoma.
    Murakami Y; Uemura K; Sudo T; Hashimoto Y; Yuasa Y; Sueda T
    World J Surg; 2010 Aug; 34(8):1900-7. PubMed ID: 20376442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Impact of Para-Aortic Lymph Node Micrometastasis in Pancreatic Ductal Adenocarcinoma.
    Komo T; Murakami Y; Kondo N; Uemura K; Hashimoto Y; Nakagawa N; Urabe K; Takahashi S; Sueda T
    Ann Surg Oncol; 2016 Jun; 23(6):2019-27. PubMed ID: 26856722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor location, clinicopathological features, and perioperative and prognostic outcomes in patients who underwent pancreatic resection following neoadjuvant chemoradiotherapy for resectable pancreatic cancer: A retrospective study.
    Suto H; Matsukawa H; Fuke T; Nagao M; Ando Y; Oshima M; Yamana H; Kamada H; Kobara H; Okuyama H; Kumamoto K; Okano K
    Pancreatology; 2024 May; 24(3):431-436. PubMed ID: 38383175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second pancreatectomy for recurrent pancreatic ductal adenocarcinoma in the remnant pancreas: A pooled analysis.
    Zhou Y; Song A; Wu L; Si X; Li Y
    Pancreatology; 2016; 16(6):1124-1128. PubMed ID: 27717684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival Impact of Pulmonary Metastasis as Recurrence of Pancreatic Ductal Adenocarcinoma.
    Yamashita K; Miyamoto A; Hama N; Asaoka T; Maeda S; Omiya H; Takami K; Doki Y; Mori M; Nakamori S
    Dig Surg; 2015; 32(6):464-71. PubMed ID: 26517228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-analysis of recurrence pattern after resection for pancreatic cancer.
    Tanaka M; Mihaljevic AL; Probst P; Heckler M; Klaiber U; Heger U; Büchler MW; Hackert T
    Br J Surg; 2019 Nov; 106(12):1590-1601. PubMed ID: 31454073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the validity of pancreatectomy for very elderly patients with pancreatic ductal adenocarcinoma.
    Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Matsunaga Y; Shiihara M; Yamamoto M
    Langenbecks Arch Surg; 2021 Jun; 406(4):1081-1092. PubMed ID: 33871713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: Proof of Concept for a "Biological R2 Definition".
    Belfiori G; Crippa S; Pagnanelli M; Gasparini G; Aleotti F; Camisa PR; Partelli S; Pecorelli N; De Stefano F; Schiavo Lena M; Palumbo D; Tamburrino D; Reni M; Falconi M
    Ann Surg Oncol; 2024 Jun; 31(6):4084-4095. PubMed ID: 38459416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DUPAN-2 as a Risk Factor of Early Recurrence After Curative Pancreatectomy for Patients With Pancreatic Ductal Adenocarcinoma.
    Sasaki A; Sakata K; Nakano K; Tsutsumi S; Fujishima H; Futsukaichi T; Terashi T; Ikebe M; Bandoh T; Utsunomiya T
    Pancreas; 2023 Feb; 52(2):e110-e114. PubMed ID: 37523601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.